Get the tools used by (smart)2 investors.

Free Cash Flow Yield for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

265.39 USD
Price
USD
Fair Value
Upside
160.19 - 289.46
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Insulet Corporation's Free Cash Flow Yield:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-4.0%-2.0%0.0%2.0%

Performance Summary
  • Insulet's latest twelve months free cash flow yield is 1.6%
  • Insulet's free cash flow yield for fiscal years ending December 2020 to 2024 averaged 0.1%.
  • Insulet's operated at median free cash flow yield of -0.1% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Insulet's free cash flow yield peaked in December 2024 at 1.6%.
  • Insulet's free cash flow yield hit its 5-year low in December 2021 of -0.9%.
  • Insulet's free cash flow yield decreased in 2021 (-0.9%, +972.6%) and increased in 2020 (-0.1%, -87.1%), 2022 (-0.2%, -72.8%), 2023 (0.3%, -215.1%), and 2024 (1.6%, +513.0%).

How does Insulet's Free Cash Flow Yield benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Insulet Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Free Cash Flow Yield

Hide this widget
fcf_yield_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Free Cash Flow Yield in the valuation category include:

  • Price / Book - Compares a firm's market value of equity to the amount of common equity listed on the balance sheet.
  • Marginal Equity Risk Premium (Operating Country) - Marginal equity risk premium in the country where the company operates over the U.S. equity risk premium as estimated by professor Aswath Damodaran at NYU Stern. Source: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html.
  • EV / EBITDA - Measures the dollars in Enterprise Value for each dollar of EBITDA over the last twelve months.
  • Daily Price High (Adjusted) - The highest trade price over the trading day.
View Full List

Search for metric or datapoint

Free Cash Flow Yield

Measures amount of free cash flow for each dollar of equity (market capitalization).

Definition of Free Cash Flow Yield

Hide this widget

Free Cash Flow Yield (FCFY) measures amount of free cash flow for each dollar of market capitalization.

Free Cash Flow Yield = Levered Free Cash Flow / Market Capitalization

Applying this formula, Insulet’s Free Cash Flow Yield is calculated below:

Levered Free Cash Flow [ $305.4 M ]
(/) Market Capitalization [ $18.637 B ]
(=) Free Cash Flow Yield [ 1.6% ]

The tables below summarizes the trend in Insulet’s Free Cash Flow Yield over the last five years:

Date Free Cash Flow Market Cap Free Cash Flow Yield
2020-12-31 -13.4 M $16.853 B −0.1%
2021-12-31 -156.5 M $18.35 B −0.9%
2022-12-31 -47.5 M $20.445 B −0.2%
2023-12-31 40.5 M $15.151 B 0.3%
2024-12-31 300.1 M $18.313 B 1.6%

Read More: Levered Free Cash Flow

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-882.9%-582.9%-282.9%41.1%0200400600

The chart above depicts the distribution of free cash flow yield for companies operating in the Healthcare sector in the Developed economic region. Over 1,990 companies were considered in this analysis, and 1,914 had meaningful values. The average free cash flow yield of companies in the sector is -43.8% with a standard deviation of 110.6%.

Insulet Corporation's Free Cash Flow Yield of 1.6% ranks in the 69.4% percentile for the sector. The following table provides additional summary stats:

Free Cash Flow Yield In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,994
Included Constituents1,914
Min-878.5%
Max34.1%
Median-7.1%
Mean-43.8%
Standard Deviation110.6%

You can find companies with similar free cash flow yield using this stock screener.

All rights reserved. Terms Of Use